Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer

The histone methyltransferase EZH2, a key epigenetic modifier, is known to be associated with human tumorigenesis. However, the physiological importance of EZH2 and its clinical relevance in endometrial cancer remain unclear. Hence, in the present study, we investigated the expression and function o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Oki, Shinya, Sone, Kenbun, Oda, Katsutoshi, Hamamoto, Ryuji, Ikemura, Masako, Maeda, Daichi, Takeuchi, Makoto, Tanikawa, Michihiro, Mori-Uchino, Mayuyo, Nagasaka, Kazunori, Miyasaka, Aki, Kashiyama, Tomoko, Ikeda, Yuji, Arimoto, Takahide, Kuramoto, Hiroyuki, Wada-Hiraike, Osamu, Kawana, Kei, Fukayama, Masashi, Osuga, Yutaka, Fujii, Tomoyuki
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5522273/
https://ncbi.nlm.nih.gov/pubmed/28418882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16316
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados